Table 3.

Comparisons of bleeding between the two groups

Outcomes	Aspirin (n = 198)	Rivaroxaban (n = 192)	P‐value
	no.%	no.%
Major bleeding	2(1.0)	1(0.5)	1.00
Clinically related bleeding	2(1.0)	3(1.6)	0.68
Minor bleeding	1(1.5)	2(1.0)	0.62
Any bleeding	5(2.5)	6(3.1)	0.77